Patient Corner

Anatomical Illustrations

More
  • Osteoporosis - Risk factors

    Osteoporosis - Risk factors

    Read more
  • What is osteoporosis?

    What is osteoporosis?

    Read more
  • Scheuermann

    Scheuermann

    Read more
  • Frequent fractures in women - The wrist

    Frequent fractures in women - The wrist

    Read more
  • Diagnosis and results obtained from the osteodensitometry test (t score)

    Diagnosis and results obtained from the osteodensitometry test (t score)

    Read more
  • Hip - Development of osteoporosis

    Hip - Development of osteoporosis

    Read more
  • Development of rheumatoid arthritis of the hand

    Development of rheumatoid arthritis of the hand

    Read more
  • Glenohumeral periarthritis the three stages of degenerative tendinitis in the rotator cuff

    Glenohumeral periarthritis the three stages of degenerative tendinitis in the rotator cuff

    Read more
  • Vertebral compression

    Vertebral compression

    Read more
  • Scheuermann

    Scheuermann

    Read more
  • Osteodensitometry test

    Osteodensitometry test

    Read more
  • Frequent fractures in women - The wrist

    Frequent fractures in women - The wrist

    Read more

Latest drug updates

  • 31 Jan 2018 - Drug Updates

Fingolimod (Gilenya▼): Risk of serious cardiac arrhythmias

New contraindications introduced for use of fingolimod in patients with pre-existing cardiac disorders.

  • 31 Jan 2018 - Drug Updates

Fingolimod (Gilenya▼): Risk of skin cancer, lymphoma and serious opportunistic infections

Monitor patients closely for skin cancers and advise patients to seek urgent attention if they develop signs or symptoms of serious infections.

  • 27 Dec 2017 - Drug Updates

Reports of progressive multifocal encephalopathy (PML) post-treatment with Cladribine (Litak, Leustat) for leukaemia

Consider progressive multifocal encephalopathy (PML) in the differential diagnosis for patients with new or worsening neurological signs or symptoms.

  • 15 Dec 2017 - Drug Updates

Patient-related factors and 3 risk-based categories should be considered while prescribing antiepileptic drugs

Core advice from 2013 remains effective while switching between different manufacturers’ products of an oral antiepileptic drug.

  • 8 Nov 2017 - Drug Updates

Gabapentin (Neurontin): Risk of developing respiratory depression without concomitant use of opioids

Advise patients on gabapentin to seek medical help if they experience any trouble breathing or are taking shallow breaths.

  • 31 Jul 2017 - Drug Updates

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

Initiate daclizumab in restricted groups of patients with limited treatment options and closely monitor liver function.

  • 28 Apr 2017 - Drug Updates

Multiple sclerosis: Rebound syndrome after stopping fingolimod (Gilenya▼) or switching therapy

HCPs advised to report adverse effects associated with fingolimod (Gilenya▼) or other treatments for multiple sclerosis.

  • 28 Apr 2017 - Drug Updates

Valproate (Epilim▼, Depakote▼): High risk of neurodevelopmental disability and birth defects

Valproate should not be prescribed to women and girls of childbearing potential unless other treatments are ineffective or not tolerated.

  • 28 Jul 2017 - Drug Updates

Bendamustine (Levact): Increased mortality when used in combination treatment outside the approved indications

Closely monitor patients for opportunistic infections as well as cardiac, neurological, and respiratory adverse events.

  • 19 Jul 2016 - Drug Updates

Rare reports of calciphylaxis in patients taking warfarin

Warfarin linked to cases of calciphylaxis, a very rare but serious condition